SOMAÍ Pharmaceuticals Australia is an Australian subsidiary of a leading EU-GMP European pharmaceutical and biotech company, SOMAÍ Group, with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceuticals portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.